CASI Pharmaceuticals, Inc.
19.10%
3,965,535
1962738
G1933S101
Dec 17, 2025
Dec 18, 2025, 06:01 AM
Reporting Persons (6)
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| WEI-WU HE, Ph.D. | Individual | 19.10% | 3,965,535 | 2,130,550 | 1,834,985 |
| EMERGING TECHNOLOGY PARTNERS, LLC | Other | 5.30% | 1,097,341 | 0 | 1,097,341 |
| ETP Global Fund L.P. | Partnership | 3.70% | 753,234 | 0 | 753,234 |
| HUIYING MEMORIAL FOUNDATION | CO | 3.10% | 637,644 | 0 | 637,644 |
| ETP BIOHEALTH III FUND, L.P. | Partnership | 1.50% | 300,000 | 0 | 300,000 |
| HE Family GRAT | Other | 0.50% | 100,000 | 0 | 100,000 |
Disclosure Items (6)
Ordinary Shares
CASI Pharmaceuticals, Inc.
1701-1702, CHINA CENTRAL OFFICE TOWER 1, BEIJING, F4, 100025
On September 16, 2025, Huiying Memorial Foundation purchased 230,000 Ordinary Shares from open market. The total amount of funds for the purchase was $469,752 and Huiying Memorial Foundation used its personal funds to complete the purchase.
See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Ordinary Shares and percentages of the Ordinary Shares beneficially owned by each Reporting Person. The percentage used in this Schedule 13D is calculated based upon 20,548,273 Ordinary Shares outstanding as of September 30, 2025.
See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Ordinary Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
On September 16, 2025, Huiying Memorial Foundation purchased 230,000 Ordinary Shares from open market at the per share price of US$2.0424.
No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.
Not applicable.
To the best knowledge of the Reporting Persons, except as provided herein and disclosed before, there are no other contracts, arrangements, understandings or relationships (legal or otherwise) between the Reporting Persons and between any of the Reporting Persons and any other person with respect to any securities of the Company, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies, or a pledge or contingency, the occurrence of which would give another person voting power over the securities of the Company.
Joint Filing Agreement by and among ETP Global Fund LP, Emerging Technology Partners LLC, ETP BioHealth III Fund, LP, HE Family GRAT and Wei-Wu He, Ph.D. dated April 18, 2023.